Skip to content

The development of Clostridioides difficile Infection is associated with the severity of liver disease and worsens survival in acutely decompensated cirrhosis.

Sep 2026 · American Journal of the Medical Sciences · 0 citations · 43 references
Medicine

TL;DR

S Severity of liver failure and recent exposure to antibiotics are risk factors for the development of CDI in acutely decompensated cirrhosis and CDI significantly increases 12-week mortality particularly in cases with the hypervirulent 027 ribotype strain.

Abstract

Clostridioides difficile infection (CDI) frequently occurs in advanced cirrhosis. We aimed to evaluate risk factors for CDI in acutely decompensated cirrhosis and its impact in relevant clinical outcomes

Methods

The study included patients with cirrhosis that were consecutively admitted for acute decompensation in a tertiary care hospital during a CDI outbreak. Data on admission, CDI ribotype, length of hospital stay, and 12-week survival were compared between patients with and without CDI.

Results

Twenty-nine out of 117 (24.7%). admitted patients developed CDI during hospitalization. Ribotype 027 was identified in 17 patients (58.6% of CDI cases). Patients with CDI had significantly worse baseline liver function, with higher MELD-sodium [19vs.14; p=0.002) and CLIF-C scores [56.6 vs. 52.0 p=0.04)] and were more frequently exposed to antibiotic therapy. Independent predictors of CDI included higher MELD-Na score [OR:1.13; p=0.002] and previous recent antibiotic use [OR: 4.93; p=0.001]. CDI was associated with a longer hospital stay [34 days (IQR 10-41) vs. 9 days (IQR 5-18); p=0.0001]. Although in-hospital mortality was similar between groups, age [OR: 1.08; (CI 95 %: 1.03- 1.13); p=0.001], MELD-sodium score [OR: 1.12 (CI 95 %:1.03 - 1.22); p=0.008], and ribotype 027 (OR: 4.25 , (CI 95 %:1.16 - 15.58); p=0.003] were independently associated with 12-week mortality.

Conclusion

Severity of liver failure and recent exposure to antibiotics are risk factors for the development of CDI in acutely decompensated cirrhosis. CDI significantly increases 12-week mortality particularly in cases with the hypervirulent 027 ribotype strain.

View source

Similar papers

Oct 2026

Clinical Profile and Outcomes of Clostridioides Difficile Infection in Noninflammatory Bowel Disease Patients: A Retrospective Study from a Tertiary Care Center.

BACKGROUND Clostridioides difficile infection (CDI) is one of the leading causes of healthcare-associated and antibiotic-associated diarrhea and is associated with significant morbidity and mortality. Data regarding the clinical characteristics and outcomes of CDI among noninflammatory bowel disease (non-IBD) patients...

Srinivas Gridhati, Sai Sarath Dasari, S. Shanmughanathan et al. · 0 citations
Open access Sep 2026

Risk factors for severe Clostridioides difficile infection in Korea: a retrospective cohort study

Background: Early identification of high-risk patients for severe Clostridioides difficile infection (CDI) is critical for timely intervention. This study evaluated antecedent factors associated with severe CDI while minimizing potential circular reasoning and reverse causality from post-diagnostic clinical course vari...

Banseok Kim, Y. A. Kim · 0 citations
Open access Oct 2026

Epidemiology and Predictors of 90-Day Mortality in Patients with Clostridioides difficile Infection: A Retrospective Single-Center Study from Galati, Romania

Higher ATLAS score and UC exposure were associated with mortality, but the UC association is exploratory because catheter timing relative to CDI diagnosis was not reliably available.

P. Nicolcescu, G. Popa, M. Matei et al. · 0 citations
Open access Oct 2026

Clinical Acuity and Total Hospitalization Burden in Liver Transplant Recipients with Clostridioides difficile Infection: A Single-Center Cohort Study

Background: Clostridioides difficile infection (CDI) in liver transplant (LT) recipients often occurs during complex postoperative care. We compared clinical characteristics and total hospital length of stay (LOS) between LT-CDI and non-LT CDI records. Materials and Methods: We analyzed 562 CDI-associated hospital reco...

Ping-Ping Wu, Si-Miao Duan, M. Xu et al. · 0 citations
Sep 2026

Clostridioides difficile infection increases the need for using biologics in patients with inflammatory bowel diseases: a retrospective long-term study.

Recognizing gastrointestinal infection promptly and integrating infection history into therapeutic decision-making may improve patient outcomes by preventing severe disease progression and guiding timely escalation of therapy.

R. Spagnuolo, G. G. M. Scarlata, Domenico Morano et al. · 0 citations
Review Open access Oct 2026

Identification and Characterization of Patient Populations at High Risk for Clostridioides difficile Infection (CDI): A Narrative Review

Clostridioides difficile infection (CDI) is a major cause of infections worldwide and can lead to life-threatening complications and a severe impact on patients’ quality of life (QoL). CDI can affect anyone, but it is generally accepted that those at greatest risk include people receiving antibiotics, of older age, and...

J. Allegretti, E. Dubberke, C. Ferreira et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.